Endo International | ENDP - أصول متداولة



أصول متداولة تغيير تاريخ
AbbVie USD 33.53B 4.47B 2026-03
Amarin USD 626.02M 23.87M 2026-03
ANI Pharmaceuticals USD 747.08M 6.03M 2026-03
Bristol-Myers Squibb USD 27.21B 2.18B 2026-03
Coherus Biosciences USD 206.71M 254.25M 2025-12
Eli Lilly USD 54.84B 794M 2026-03
Heron Therapeutics USD 228.98M 9.08M 2026-03
Hikma Pharmaceutical USD 2.64B 86M 2025-12
Ligand Pharmaceuticals USD 865.42M 33.14M 2026-03
Merck USD 35.02B 8.5B 2026-03
Novartis USD 26.61B 3.85B 2026-03
Pacira USD 514.96M 33.01M 2026-03
Perrigo USD 2.71B 85M 2026-03
Pfizer USD 42.82B 76M 2026-03
Phibro Animal Health USD 894.07M 31.88M 2026-03
Supernus Pharmaceuticals USD 731.58M 87.4M 2026-03
Takeda JPY 3.09T 25.94B 2026-03
Teva Pharmaceutical Industries USD 13.71B 236M 2026-03
Xeris Pharmaceuticals USD 251.68M 11.37M 2026-03
Zoetis USD 6.47B 294M 2026-03